Publication Name	World Journal of Psychiatry
Manuscript ID	90856
Country	China

Received	2023-12-17 12:48
Peer-Review Started	2023-12-17 12:48
First Decision by Editorial Office Director	2024-01-10 09:27
Return for Revision	2024-01-10 09:27
Revised	2024-01-15 11:10
Publication Fee Transferred
Second Decision by Editor	2024-02-04 03:02
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-02-04 06:11
Articles in Press	2024-02-04 06:11
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-07 06:31
Publish the Manuscript Online	2024-03-19 10:56

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Clinical Neurology
Manuscript Type	Case Control Study
Article Title	Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease
Manuscript Source	Unsolicited Manuscript
All Author List	Zeng-Ling Liu, Fei-Fei Hua, Lei Qu, Na Yan and Hui-Fang Zhang
Funding Agency and Grant Number
Corresponding Author	Hui-Fang Zhang, MMed, Staff Physician, Department of Neurology, Dongying People's Hospital, No. 317 Dongcheng South 1st Road, Dongying District, Dongying 257000, Shandong Province, China. huifangzhang2@163.com
Key Words	Alzheimer's disease; Biomarkers; CXCL12; sCD22; Lp-PLA2
Core Tip	This study uncovers the diagnostic potential of serum CXCL12, sCD22, Lp-PLA2 levels, and their ratios in Alzheimer's disease (AD). The research reveals distinct patterns in these biomarkers among AD patients, providing insight into their roles in neuroinflammation and immune regulation. The findings suggest these serum markers, especially when combined as ratios, could enhance AD diagnosis, offering a non-invasive approach to early detection and intervention.
Publish Date	2024-03-19 10:56
Citation	Liu ZL, Hua FF, Qu L, Yan N, Zhang HF. Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease. World J Psychiatry 2024; 14(3): 380-387
URL	https://www.wjgnet.com/2220-3206/full/v14/i3/380.htm
DOI	https://dx.doi.org/10.5498/wjp.v14.i3.380

Full Article (PDF)	WJP-14-380-with-cover.pdf